World-class care without delay

As the UK’s leading independent oncology specialist, we are dedicated to providing the latest evidence-based treatments from around the world, in a high quality, safe environment – without delay.

Our 14 outpatient oncology centres continue to provide access to the latest diagnostics, medical oncology and radiation oncology treatments. All of our centres and clinics are operating without delay throughout the current pandemic, with extra precautionary measures in place to maintain a safe environment for our patients and teams.

Our goal is to deliver exceptional treatment and care in a way that enhances every aspect of the patient’s cancer journey. From diagnosis through to palliative care, all our patients receive the very best personalised care and a consultant-led treatment plan which also embraces proven life-changing integrative cancer care approaches such as exercise medicine and wellbeing therapies.

Fully integrated pathways

Working closely with local and regional oncologists and surgeons in conjunction with partner hospitals, we deliver rapid access pathways – with five days from plan to treatment.

Patients can be referred directly for diagnostics or to one of the many leading surgeons or oncologists who work with us.

We use the latest-generation technology to accurately diagnose and plan. Diagnostic appointments are usually available on the same day and we have specialist clinics including One Stop Breast and UrologyHub as part of our fully integrated care pathways.

Refer to one of our centres

Download a referral form or make an enquiry
Get started

Advanced radiotherapy as standard

At GenesisCare we offer many advanced radiotherapy techniques as standard to our patients and have invested in the latest technologies that have been proven to make a difference to cancer outcomes.

Often these treatments are not widely available, but we work closely with our oncologists and clinical teams to safely deliver evidence-based treatments wherever possible.

An example of an advanced technology that improves patient experience is stereotactic ablative radiotherapy (SABR) which enables treatment of a number of tumour types using a small number of fractions – five or less. This hypofractionated approach is non-invasive and has obvious benefits in limiting treatment episodes or avoiding surgery. We work with some of the country’s leading SABR specialists and have significant expertise and capacity across our 14 centres to treat a wide range of tumour types, including with SABR for lung, pancreas and liver, brain (stereotactic radiosurgery), prostate and oligometastatic disease.

We also have the UK’s first MRIdian for MRI-guided SABR in our centre in Oxford for improved treatment options for difficult-to-reach tumours such as the pancreas, and specialist neuro-oncology centres in London and Oxford.  These advanced facilities are available to any patients across the UK.

Quotation symbol

I can’t express how life-changing it is to see your condition improving instead of sitting and waiting for something to go wrong. There is life after cancer

Doug, patient at GenesisCare
Make an enquiry

Breast radiotherapy in five visits

We have adopted the FAST-Forward schedule for breast cancer radiotherapy, which found that a 26Gy/5 fraction accelerated regime is considered to be equivalent in efficacy and toxicity to the standard 40Gy/15 fraction regime. By incorporating this into our protocols we have been able to continue to treat breast cancer patients without delay and offer them the reassurance of fewer visits.

Read Angela’s story

Angela's story - GenesisCare patient
I’m so grateful I’m not still waiting for breast cancer treatment Angela, patient at GenesisCare

Angela, who is 59-years-old and from Coventry, was diagnosed with breast cancer in March 2020 following a routine mammogram.

In June, Angela had a mammoplasty operation through the NHS to remove the Ductal Carcinoma in Situ (DCIS) which was in one of her milk ducts. Adjuvant (or preventative) radiotherapy was due to take place soon after but because of the COVID-19 pandemic, Angela’s NHS treatment was delayed so she decided to use her private medical insurance.

Angela was referred to Consultant Oncologist Dr Penny Kechagioglou and they agreed she would have FAST-Forward* five-fraction breast and tattoo-free radiotherapy treatment. This meant that Angela could have her radiotherapy treatment shortened to 5 days as five-fraction breast treatment delivers higher radiation therapy over fewer sessions. It allowed Angela, who lives alone, to get back to seeing friends and family faster following a reduced period of self-isolation.

The tattoo-free treatment was delivered using surface-guided radiation therapy and means Angela has no permanent reminder of the cancer on her skin.

Angela’s treatment took place at the end of August and she is now looking forward to planning her 60th birthday next year.

She said: “My diagnosis means I unfortunately missed some key family events such as my nephew’s 18th birthday – the first of my nephews’ birthdays I have ever missed – which is why I’m so grateful I’m not still waiting for breast cancer treatment and can start to put that part of my life behind me.”

*FAST-Forward is a large clinical research programme published in May 2020 which had shown that instead of receiving radiation over 15 treatments (or fractions) with an overall dose of 40Gy, breast cancer patients could safely undergo 5 treatments with 26Gy and achieve the same result. Based on this evidence, GenesisCare decided to make this available for all suitable patients.

Refer to one of our centres

Download a referral form or make an enquiry
Get started

Committed to our patients

Keeping our patients and teams safe

We are proud that so many of our patients rate our care as excellent and we are committed to supporting clinicians during these immensely difficult and challenging times and ensuring that our patients continue to receive the best possible care without delay.

Most of our centres are standalone, and all are outpatient facilities with low footfall. We are closely monitoring the Coronavirus (COVID-19) pandemic globally, implementing the latest Government advice, and have extra precautionary measures in place to maintain a safe environment for our patients and teams.

If required we can help your patients with transport, depending on treatment and locations.

We are a patient-first organisation and aim to provide exceptional care in everything we do. Many of our centres are rated good by the CQC and carry the Macmillan Quality Environment Mark (MQEM).

You have all been so amazingly comforting and attentive when I have needed it. Patient, Bristol

We have adopted evidence-based national and international clinical protocols which are advocated by our specialist cancer Multidisciplinary Team Forums. We have also optimised our radiotherapy techniques to ensure best possible outcomes for our patients.

Frequently asked questions

Clinicians and patients are anxious to continue their cancer treatment without delay. Typically, our patients are funded through private medical insurance but during the current circumstances we have reduced our prices to make it more accessible to those who want to fund the cost of their own treatment.

To get the most benefit from their private health insurance, we recommend that your patient contacts their insurance company at the point of diagnostic referral.

At GenesisCare, a cancer diagnosis, personalised treatment plan and private medical insurance approval can take as little as 24 hours.

At GenesisCare we receive referrals from two main pathways:

  • Our diagnostic One Stop Clinics
  • Directly from our Surgeons and Oncologists

We endeavour to treat patients within five to seven days from referral. These timings depend on whether we have all the histology results available for the cancer MDTs to make treatment decisions, otherwise we operate on full workforce capacity in terms of radiotherapy planners, physicists, therapy radiographers and chemotherapy nurses.

Our clinical reference groups and UK Leadership Team work closely with the NHS, RCR, ESTRO and other surgical and oncology associations to ensure that our revised clinical protocols are aligned with national clinical guidelines.

All patient referrals for new protocols are reviewed by our clinical reference groups and clinical advisory team to ensure compliance with eligibility criteria.


Our centres

All 14 of our specialist oncology outpatient centres can treat without delay and are able to accept new referrals.
View centre details